WASHINGTON – GenBioPro, which sells the generic version of the abortion pill mifepristone, hired its own team of lobbyists for the first time this summer, according to new federal disclosures.
GenBioPro has hired two lobbyists from the firm Emergent Strategies to advocate on “Issues related to medication abortion … abortion access [and] FDA Approval of Mifepristone,” its filing states. Emergent officially registered to represent GenBioPro on July 11.
Create a display name to comment
This name will appear with your comment